2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid has been researched along with tritrpticin in 1 studies
| Studies (2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid) | Trials (2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid) | Recent Studies (post-2010) (2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid) | Studies (tritrpticin) | Trials (tritrpticin) | Recent Studies (post-2010) (tritrpticin) |
|---|---|---|---|---|---|
| 65 | 0 | 20 | 32 | 0 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcisio-Miranda, M; Bozelli, JC; Nakaie, CR; Procopio, J; Riciluca, KCT; Salay, LC; Schreier, S; Silva Junior, PI | 1 |
1 other study(ies) available for 2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid and tritrpticin
| Article | Year |
|---|---|
A comparison of activity, toxicity, and conformation of tritrpticin and two TOAC-labeled analogues. Effects on the mechanism of action.
Topics: Antimicrobial Cationic Peptides; Cell Membrane; Cyclic N-Oxides; Erythrocytes; Escherichia coli; Humans; Micrococcus luteus; Oligopeptides | 2020 |